Cargando...

Management of patients with HBeAg‐negative chronic hepatitis B

Chronic hepatitis B (CHB) is one of the leading causes of morbidity and mortality worldwide. Although various drugs are available for the treatment of CHB, emergence of the hepatitis B e antigen (HBeAg)‐negative mutant variant, specifically in Asia, the Middle East and southern Europe, is creating a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Saikia, Nripen, Talukdar, Rupjyoti, Mazumder, Subhasish, Khanna, Sudeep, Tandon, Rakesh
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Group 2007
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2599959/
https://ncbi.nlm.nih.gov/pubmed/17267676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/pgmj.2006.044826
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!